Literature DB >> 29074430

Role of Th17 and Treg cells in septic arthritis and the impact of the Th17/Treg -derived cytokines in the pathogenesis of S. aureus induced septic arthritis in mice.

Ipsita Dey1, Biswadev Bishayi2.   

Abstract

Intravenous inoculation of Swiss mice with S. aureus leads to severe synovial joint tissue swelling along with prominent T lymphocyte infiltrate with associated inflammation in synovial tissue. Cytokines released from macrophages such as TNF-α, IL-1β and IL-6 the main players that precede cartilage and bone destruction during septic arthritis (SA) followed by osteoclast differentiation and bone resorption. CD4+ naïve T cells upon cytokine driven activation, differentiate into lineages of helper (Th) and regulatory T cells (Treg) including inflammatory Th17 cell lineage. Acting as counterbalance, Tregs protect the host by releasing anti-inflammatory IL-10. A disturbed balance between Th17 and Treg cell development skews the pathways towards Th17 lineage, but how it actually induces SA is still unexplored. Therefore, this study has been attempted to demonstrate the Th17/Treg ratio in synovial tissue, spleen and peripheral blood by FACS and their derived cytokines from serum of arthritic mice. Here, we reported that the ratios of Th17/Treg as well as their related cytokine levels were increased at 3 days post-infection which was decreased during 9 DPI but heightened again at 15DPI resulting in persistence of the disease, though decreased again at 30 DPI even in animals with increased dose of infection. Bacterial colonies were present in synovial joints at 15 DPI in animals with increased infection but found to be absent at 30 DPI. Maintaining Th17/Treg balance by neutralizing functionally active Th17 and their related cytokines or adoptive transfer of fully active Tregs and/or their related cytokines may lead to a novel therapeutic strategy for combating Staphylococcal arthritis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IL-17A; IL-23; Joint inflammation; Lymphocytes; Septic arthritis; Th17/Treg ratio

Mesh:

Substances:

Year:  2017        PMID: 29074430     DOI: 10.1016/j.micpath.2017.10.033

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  6 in total

1.  Bortezomib alleviates antibody-mediated rejection in kidney transplantation by facilitating Atg5 expression.

Authors:  Hong Cheng; Bin Xu; Lijie Zhang; Yi Wang; Ming Chen; Shuqiu Chen
Journal:  J Cell Mol Med       Date:  2021-11-03       Impact factor: 5.310

2.  Transcriptome Architecture of Osteoblastic Cells Infected With Staphylococcus aureus Reveals Strong Inflammatory Responses and Signatures of Metabolic and Epigenetic Dysregulation.

Authors:  Aurélie Nicolas; Martine Deplanche; Pierre-Henri Commere; Alan Diot; Clemence Genthon; Wanderson Marques da Silva; Vasco Azevedo; Pierre Germon; Hélène Jamme; Eric Guédon; Yves Le Loir; Fréderic Laurent; Hélène Bierne; Nadia Berkova
Journal:  Front Cell Infect Microbiol       Date:  2022-04-07       Impact factor: 6.073

Review 3.  Exploring the Role of Staphylococcus aureus in Inflammatory Diseases.

Authors:  Huanquan Chen; Junyan Zhang; Ying He; Zhuoyi Lv; Zhengtong Liang; Jianze Chen; Peishan Li; Jiawei Liu; Hongchen Yang; Ailin Tao; Xueting Liu
Journal:  Toxins (Basel)       Date:  2022-07-06       Impact factor: 5.075

4.  MiR-206 regulates the Th17/Treg ratio during osteoarthritis.

Authors:  Xiguang Ye; Qilin Lu; Aofei Yang; Jun Rao; Wei Xie; Chengjian He; Weijun Wang; Hao Li; Zhiwen Zhang
Journal:  Mol Med       Date:  2021-06-19       Impact factor: 6.354

5.  Staphylococcus aureus Protein A Induces Human Regulatory T Cells Through Interaction With Antigen-Presenting Cells.

Authors:  Julia Uebele; Katharina Habenicht; Olga Ticha; Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-09-30       Impact factor: 7.561

Review 6.  T Cell Protein Tyrosine Phosphatase in Osteoimmunology.

Authors:  Ya-Nan Wang; Shiyue Liu; Tingting Jia; Yao Feng; Wenjing Zhang; Xin Xu; Dongjiao Zhang
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.